---
category: listing
circular_id: ed7f8c4b070e93bf
date: '2026-01-09'
description: BSE announces listing of 2000 bonus equity shares of Sun Pharmaceutical
  Industries Ltd. kept in abeyance, effective January 12, 2026.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={29B3B219-27B3-43A0-ABAB-A30920055463}&noticeno=20260109-21&dt=01/09/2026&icount=21&totcount=70&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Administrative listing of small number of bonus shares previously kept
  in abeyance; minimal market impact due to limited quantity (2000 shares)
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20260109-21&attachedId=
processing:
  attempts: 1
  content_hash: d2b35eb026556e52
  processed_at: '2026-01-09T19:10:29.066107'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2026-01-09T12:55:42+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={29B3B219-27B3-43A0-ABAB-A30920055463}&noticeno=20260109-21&dt=01/09/2026&icount=21&totcount=70&flag=0
severity: low
source: bse
stocks:
- SUNPHARMA
tags:
- bonus-shares
- listing
- sun-pharma
- equity
- abeyance
title: Listing of 2000 Bonus Equity Shares Kept in Abeyance - Sun Pharmaceutical Industries
  Ltd.
---

## Summary

BSE has announced the listing of 2000 bonus equity shares of Sun Pharmaceutical Industries Ltd. (Scrip Code: 524715) that were previously kept in abeyance. These shares will be listed and permitted to trade with effect from Monday, January 12, 2026.

## Key Points

- 2000 bonus equity shares of Rs. 1/- each to be listed
- Company: Sun Pharmaceutical Industries Ltd.
- Scrip Code: 524715
- ISIN: INE044A01036
- Trading commencement date: January 12, 2026
- Shares were previously kept in abeyance

## Share Details

**Distinctive Number Ranges:**
- 1000 shares: Distinctive No. 1035573706 to 1035574705
- 1000 shares: Distinctive No. 1042698157 to 1042699156

## Regulatory Changes

No regulatory changes introduced. This is a standard listing notification for bonus shares that were previously held in abeyance.

## Compliance Requirements

Trading members are informed to note the listing of these securities for trading purposes effective from the specified date.

## Important Dates

- **Notice Date:** January 9, 2026
- **Listing and Trading Commencement:** January 12, 2026 (Monday)

## Impact Assessment

Minimal market impact expected as this involves a small quantity of bonus shares (2000 shares) that were previously kept in abeyance. This is an administrative action to release shares that were held pending resolution of specific issues. The limited number of shares will have negligible effect on Sun Pharma's overall trading or market capitalization.